Cannabis and Cannabinoids for Therapeutic Purposes
Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use. Kevin Hill, MD, MHS, of Harvard Medical School joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about the therapeutic use of cannabis and cannabinoids in adults, potential harms, and evidence-based clinical guidance. Related Content: Therapeutic Use of Cannabis and Cannabinoids
--------
13:00
--------
13:00
Diagnosis and Treatment of Peripheral Neuropathy
Peripheral neuropathy affects approximately 1% of adults worldwide and can be associated with significant disability. Author Michelle Mauermann, MD, of the Mayo Clinic in Minnesota joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss diagnosis and optimal management of peripheral neuropathy. Related Content: Peripheral Neuropathy
--------
22:00
--------
22:00
Diagnosis and Treatment of MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD), an increasingly prevalent condition among adults worldwide, is associated with liver-related complications, hepatocellular carcinoma, and certain extrahepatic cancers. Author Norbert Stefan, MD, from the University Hospital of Tübingen in Tübingen, Germany, discusses this and more with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content: Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults ----------------------------------- JAMA Editors' Summary
--------
26:21
--------
26:21
Moving Toward a Safer World by 2040
The JAMA Summit on Firearm Violence convened 60 thought leaders from a wide array of disciplines to chart a roadmap that could lead to substantial reductions in firearm harms by 2040. Frederick P. Rivara, MD, MPH, of the University of Washington joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the Summit and steps that could lead to a safer world by 2040. Related Content: Toward a Safer World by 2040 Reducing Firearm Violence and Harms ----------------------------------- JAMA Editors' Summary
--------
15:54
--------
15:54
Treatment of Keratinocyte Carcinoma
Keratinocyte carcinomas, which include basal cell carcinoma and squamous cell carcinoma, are common forms of skin cancer. Approximately 5.4 million keratinocyte carcinomas are diagnosed in the US annually. Author Mackenzie R. Wehner, MD, MPhil, of the University of Texas MD Anderson Cancer Center joins JAMA Associate Editor David Simel, MD, MHS, to discuss treatment of these types of nonmelanoma skin cancer. Related Content: Keratinocyte Carcinoma ----------------------------------- JAMA Editors' Summary
México